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Summary Photofrin levels in cells derived from SCCVII tumours, excised from mice that previously received
the drug, were measured using a fluorescence activated cell sorter (FACS). Concomitantly, in the same cells
the FACS was used to measure fluorescein isothiocyanate (FITC) fluorescence that originated from FITC-
conjugated antimouse IgG added to the cell suspension before sorting. This later measurement enabled
discrimination between IgG negative tumour malignant cells and IgG positive host cells (primarily mac-
rophages). In addition, cellular Photofrin content in 'tumour' and 'host' cells sorted by FACS was determined
by chemical extraction. The measurements were performed for the time intervals 1-96h post Photofrin
administration. The data showed consistently higher Photofrin levels in the 'host cells', i.e., tumour associated
macrophages (TAM), than in 'tumour' cells. On a per cell basis, at any time point studied there was a
minimum of 1.7 times more Photofrin in 'host' than in 'tumour cells', while at 4-12h postadministration,
ratios of up to 3.0 times were observed. This corresponds to ratio values greater than 9, when based on
Photofrin content per ;Lg cell protein.
Tumour localising capacity of Photofrin and other photosen-
sitising drugs which is essential for their use in photodynamic
therapy (PDT) is still under investigation. Besides tumours,
the normal tissues showing most prominent accumulation of
these sensitisers (liver, kidney, spleen, lymph nodes, skin) are
all characterised by the presence of cells of mononuclear-
phagocyte system, also called reticuloendothelial system
(Bugelski et al., 1981). On the other hand, efficiency of
tumour destruction by PDT is related not only to the tissue
distribution of the administered photosensitiser, but also to
its distribution within the tumour (Henderson & Bellnier,
1989).
Since the observation by Bugelski et al. (1981) that macro-
phages scattered throughout a mouse tumour contained
particularly high levels of HPD (hematoporphyrin deriva-
tive), there has been increasing evidence that porphyrins,
phthalocyanines and some other photosensitisers of potential
use in PDT accumulate in macrophages in high levels. Jori
(1989) has concluded that tightly aggregated sensitiser
material can be entrapped in the interstitial regions of the
tumour and localise in macrophages, or enter neoplastic cells
via pinocytosis. Henderson and Bellnier (1989) have sug-
gested that macrophages exhibit extremely high affinity for
Photofrin and may significantly contribute to the overall
PDT response.
Using flow cytometric analysis and cell sorting Chan et al.
(1988) have studied the levels of chloroaluminum sulfonated
phthalocyanine (AICISPC) in components of a mouse colo-
rectal carcinoma. Based on sensitiser fluorescence, popula-
tions of high and low sensitiser content were separated from
suspensions of dispersed tumours after in vivo sensitiser
administration. Their analysis based on morphological cri-
teria and nonspecific esterase staining for cell identification
showed that photosensitiser was bound to tumour cells and
macrophages, while tumour associated lymphocytes and
polymorphonuclear leukocytes were free of photosensitiser.
In this work, we have used fluorescence activated cell
sorting to examine photosensitiser level in cells from excised,
disaggregated tumours. By using a dual staining technique,
we identified a subset of cells which showed increased reten-
tion of the photosensitiser.
Materials and methods
Animals and tumour
Female C3H mice 9-11 weeks of age were used in all
experiments. The SCCVII squamous cell carcinoma was
maintained by intramuscular passage. For experiments,
tumours were implanted subcutaneously over the sacral
region of the back. Full details of implantation and main-
tenance of the tumour cell line have been described elsewhere
(Chaplin et al., 1987). Tumours were used when they attained
a size of 500-800 mg (wet weight).
Photofrin preparation
Photofrin was kindly provided by Quadralogic Technologies
(QLT) Phototherapeutics Inc. (Vancouver, BC). All experi-
ments were performed with the dose 25 mg kg-' body weight,
by injecting 0.2 ml of the original Photofrin solution (2.5 mg
ml-') via tail vein.
FACS analysis
At indicated times 1-96 h after Photofrin administration the
animals were sacrificed and the tumours were excised. After
weighing, the tumour tissue was minced with scalpel blades
and the resulting pieces were enzymatically dissociated as
described previously (Chaplin et al., 1987). The cells were
then resuspended in Eagle's Minimum Essential Medium
(MEM) supplemented with 10% foetal bovine serum (FBS)
(Gibco, Grand Island, NY); the concentration of cells in the
resulting suspension was adjusted to 1-2 x 107 cells ml-'.
Goat antimouse IgG (whole molecule) conjugated with fluor-
escein isothiocyanate (FITC) was then added to the cell
suspension at 1:200 (v:v) final dilution of the original
preparation by Sigma Chemical Co (St. Louis, MO), as
described previously (Olive, 1989). Antibody to mouse IgG
raised in goats or other animals can bind directly to Fc
receptor found on the membrane surface of macrophages,
lymphocytes and granulocytes, or bind to mouse IgG already
bound to the Fc receptor (Lindsay et al., 1982; Olive, 1989).
After 1 min the cells were subjected to centrifugation (5 min)
to wash away the unbound antibodies. The cells were then
resuspended in 5 ml of ice cold medium and processed
immediately by a dual laser fluorescence activated cell sorter
(FACS 440, Becton-Dickinson, Mountainview, CA) to avoid
internalisation of IgG antibodies.
IgG positive and IgG negative cells were simultaneously
analysed for intensity of Photofrin fluorescence. Fluorescein
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was excited by the 488 nm laser and the resulting emission
was measured through a 530 ± 15 nm bandpass filter. Photo-
frin was excited by the UV lines (350-360 nm) and emission
recorded through a 635 nm longpass filter. A range of
1-2 x 104 cells were analysed per sample in these measure-
ments. In addition, 0.5-1.0 x 106 IgG positive and IgG
negative cells were sorted for independent determinations of
Photofrin content using chemical extraction of porphyrin
material from the cells.
Photofrin measurementfrom cell extracts
Following centrifugation of the cell suspension collected from
FACS, 3 ml of ScintiGest tissue solubiliser (Fisher Scientific
Co., Fair Lawn, NJ) at 1:10 aqueous dilution (v:v) was
added to the cell pellet. ScintiGest readily dissolves cells
leaving a clear solution with no precipitate. The hydrolysis of
porphyrin material and of cellular protein was facilitated by
leaving the samples overnight at 60°C. As a result, all Photo-
frin components are converted into a more uniform material
with optimal fluorescence yield (Korbelik & Hung, 1991;
Brown & Vernon, 1990). This allows the determination of
Photofrin content using a fluorometric assay. Fluorescence in
the cell extracts was measured by a System 3 Scanning
Spectrofluorometer (Farrand Optical Co., Valhalla, NY). The
fluorescence intensity recorded was at the maxima for excita-
tion and emission, at 405 and 625 nm, respectively. The
actual Photofrin concentration was determined using stan-
dard calibration curves obtained with known photosensitiser
concentrations.
Separation by differential cell attachment
Macrophages have a capacity for fast and firm attachment to
a plastic substrate, while SCCVII tumour cells need a much
longer time for firm substrate attachment. This can be
exploited for obtaining separate populations of tumour cells
and TAM (Russell et al., 1980). Single cell suspension in
MEM with 10% FBS was prepared from SCCVII tumour as
described above. The cells were plated into 100 mm Petri
dishes (Falcon 3003, by Becton Dickinson and Comp., Lin-
coln Park, NJ) at a concentration of 5-6 x 106 cells per dish
and left 5 min in the C02-incubator at 37°C. The supernatant
was then removed and non-attached cells rinsed with two
washes using 5 ml of the medium. The attached cells con-
sisted almost exclusively of macrophages. Over 85% of these
cells were positively stained for non-specific esterase, and the
morphology of some non-positively stained cells suggested
that they were macrophages. The non-attached cells in the
original supernatant and in the two washings were pooled
togther and transferred into a second 100 nm Petri dish. The
macrophages remaining in the cell suspension were allowed
to attach to the bottom surface of this second dish by 10 min
incubation at 37°C. The non-attached cells remaining sus-
pended in the medium were finally plated into a third 100 nm
Petri dish, or they were taken immediately for determination
of Photofrin content. The tumour cell population obtained
by this procedure contained no positively stained cells for
non-specific esterase.
Statistical analysis was performed using Student's t-test.
Results
The distribution offluorescence intensities in SCCVII tumour
cells exposed to Photofrin and FITC-conjugated antimouse
IgG is shown in Figure 1. Similar separation into two distinct
populations by bivariate analysis has been obtained in other
experiments in this study. Photofrin associated cell fluore-
scence originated from the drug administered to the mice
before tumour excision, while fluorescein fluorescence came
from FITC-conjugated antimouse IgG added to the tumour
derived single cell suspension 5 min before FACS analysis.
As seen in Figure 1, the population of cells characterised by
high fluorescein-associated fluorescence (IgG positive) also
exhibited high Photofrin fluorescence. The other cell popula-
tion was marked by very weak (if any) fluorescein fluore-
scence and lower intensity of Photofrin fluorescence. The
insert in Figure 1 depicts the size of IgG positive and IgG
negative populations in SCCVII tumour. Approximately
40% of all cells in the tumours were IgG positive, while the
rest were IgG negative.
The Photofrin fluorescence in IgG positive and IgG nega-
tive populations was determined by FACS from a series of
SCCVII tumours excised at different times after the adminis-
tration of Photofrin to mice (Figure 2). In both cell popula-
tions Photofrin content increased with time and reached a
maximum 12 h after the drug administration. This was fol-
lowed by a steady decrease in Photofrin levels in both cell
populations at 2, 3 and 4 days after the administration of the
photosensitiser. With IgG negative cells this decrease was
statistically significant only at 96 h. The Photofrin level in
IgG positive populations was constantly higher than in IgG
negative populations at all the time intervals examined.
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Figure 1 Typical FACS 440 bivariate plot of FITC conjugated
antimouse IgG stained cell suspension derived from SCCVII
tumour excised from a mouse which received Photofrin (the
contour levels are 10, 20, 40, and 80%). The insert shows the
distribution of cells from the same suspension on the basis of
binding of IgG antibodies.
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Figure 2 Photofrin fluorescence intensity in tumour cells (IgG
negative) (A) and in host cells (IgG positive) (A) sorted from
SCCVII tumour cell suspension and measured by FACS 440. The
measurement was performed for a series of tumours (three or
more per point) excised at different times post administration of
Photofrin (25 mgkg-'). ** = values at the time points later than
12h that are significantly lower (P<0.005). Bars represent stan-
dard deviations.
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The two cell populations sorted by FACS were collected
and subjected to an independent method of Photofrin con-
tent measurement employing chemical extraction of porphy-
rin material from the cells. The results of these measurements
(Figure 3) are similar to the results obtained by FACS
(Figure 2), also showing constantly higher levels of the
photosensitiser in IgG positive tumour population. The
Photofrin content reached its highest level at 24 h post-
administration of the drug. In the next 2 days Photofrin
levels decreased more rapidly in IgG positive, than in IgG
negative cell populations. Compared to the value at 24 h, the
decrease was statistically significant at 72 and 96 h with IgG
positive cells, and at 72 h with IgG negative cells.
The results for Photofrin measurement shown in Figures 2
and 3 are expressed on per cell basis and thus do not take
into account marked difference in size and protein content
that exists between cells found in IgG positive and in IgG
negative populations. There is nearly a 3-fold difference in
the protein content between these two cell populations. The
cell protein determination based on the Lowry method
showed that isolated tumour malignant cells have 278 pg of
protein per cell, whereas the value obtained with isolated
macrophages was 92 pg protein per cell. For IgG positive
cells, the measurements in Figure 3 with Photofrin content
calculated per jig cell protein gives 0.38 and 0.18 ng of
Photofrin per jig of cell protein at 24 and 96 h, respectively.
The values at 24 and 96 h with IgG negative cells are 0.05
and 0.04 ng of Photofrin per pg of cell protein, respectively.
The analysis of Photofrin per weight of cell protein clearly
emphasises the higher levels of the photosensitiser accumu-
lated in IgG positive populations.
The ratios of the Photofrin levels determined in IgG posi-
tive and IgG negative populations, expressed on a per cell
basis, are shown in Figure 4. The ratio values derived from
FACS measurement are always greater than 1.7, and reach
2.7 at 12 h post Photofrin administration. Compared to the
value as 12 h, the ratios at 1 and 24 h are significantly lower,
while at the other time points the difference is not statistically
significant. The comparative ratio values derived from the
porphyrin extraction method shown on the same graph are
very similar, except that the maximal value (3.0) is already
reached at the 4 h time point. Compared to this maximal
value, the ratios at 48, 72 and 96 h are significantly lower
(P<0.005), while at the other time points the difference is
not statistically significant.
The calculation, based on weight of cell protein of the
IgG + /IgG - ratios of Photofrin content obtained with the
extraction method, give essentially the values shown in
Figure 4 multiplied by a factor 3.02, since there is by that
much more protein contained in IgG negative cells compared
to IgG positive cells. Such analysis shows that IgG positive
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Figure 3 Photofrin content in two populations of SCCVII
tumour cells (IgG positive (A) and IgG negative(A)) sorted by
FACS, as determined by the fluorometric assay from the cell
extracts. The FACS measurement of Photofrin fluorescence in the
same samples is shown in Figure 2. Values at the time points
later than 24 h that are significantly lower: ** = P<0.005;
* = P<0.01.
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Figure 4 The ratios of Photofrin content determined in IgG
positive: IgG negative cell populations derived from SCCVII
tumours. The ratio values were derived from the data shown in
Figure 2 (FACS measurement) (0) and in Figure 3 (chemical
extraction of porphyrin from the cells) (U). Values significantly
lower than the values at 4 h (cell extracts), or 12 h (FACS
measurement): ** = P<0.005; * = P<0.01.
cells can accumulate 9.2 times more Photofrin on a per cell
protein basis at the peak time, i.e. 4 h post Photofrin admin-
istration.
Results of Photofrin content measurement in populations
of SCCVII tumour derived cells separated by the differential
attachment procedure are shown in Table I. With this differ-
ent separation technique, the TAM population again showed
much higher levels of Photofrin than the tumour cell frac-
tion. The measurement, taken at 24 h post administration of
the drug, showed Photofrin level in the tumour cells fraction
very similar to that obtained with FACS sorted IgG negative
cells (Figure 3, 24 h). The photosensitiser level in the TAM
fraction, however, was over two times higher than in FACS
sorted IgG positive cell, i.e. 7.37 compared to 3.6 tLg of
Photofrin per 10' cells.
The issue of a possible disproportionate photosensitiser
loss from different cells during the exposure to the enzymatic
digestion procedure used for dissociation of cells from
tumour tissue was analysed in a separate in vitro experiment.
Three different types of cells, SCCVII tumour cells, SCCVII
TAM, and peritoneal macrophages from C3H mice, were
exposed to Photofrin, and then harvested either by using a
rubber policeman, or by employing the enzymatic procedure
identical to that used for dissociating cells from tumour
tissue. The results (Table II) demonstrate that macrophages
(both TAM and peritoneal) accumulate more Photofrin than
tumour cells under these in vitro conditions. In addition, the
data reveal that the enzymatic digestion induced loss of
cellular Photofrin. The loss was approximately 60% with
tumour cells, and around 75% with both types of macro-
phages.
Discussion
One of the most reliable methods for discrimination between
tumour cells and host cells in a solid tumour is based on the
presence of surface receptors for Fc section of immuno-
Table I Photofrin content in tumour cells fraction and TAM fraction,
derived from SCCVII tumour and separated by differential substrate
attachment
Photofrin content Ratio
(jig 10-8 cells) (TAM:tumour cells)
Tumour cell fraction 1.50±0.17a 4.9±0.9
TAM fraction 7.37± 1.30
Tumours excised 24 h after Photofrin administration (25 mg kg-').
Photofrin content determined by porphyrin extraction followed by
fluorometric measurement (see Materials and methods). aStandard
deviations given.PHOTOFRIN IN TUMOUR CELLS AND MACROPHAGES 511
TableII Theeffectofexposure toamixtureoftrypsin,collagenaseand
DNAase on Photofrin levels in tumour cells and macrophages
Photofrin content (jAg 10-8 cells)
Mechanical detachment Enzymatic treatment
SCCVII tumour cellsa 10± 1.8b 3.8±0.3
TAM 62±18 15±3
Peritoneal macrophages 80± 15 21 ± 1
Cellswereexposed to 101sgPhotofrin ml' ingrowthmedium(MEM
with 1% FBS) for 24 h at 37°C. Subsequently, cells were rinsed with
phosphate buffered saline, and then harvested using either a rubber
policeman, or by exposure to the enzymatic digestion procedure,
identical to that used in dissociation of cells from tumour tissue.
Photofrincontentwasdeterminedbyporphyrinextractionfromwashed
cell pellets, followed by fluorometric measurement. aTumour cells and
TAM were selected from SCCVII tumours by differential detachment
procedure (see Materials and methods); tumour cells were cultivated in
vitro for 2 weeks before the experiment. Cultures with peritoneal
macrophages were isolated from C3H mice as described elsewhere
(Korbelik et al., 1991). bStandard deviations given.
globulin in the membranes of the host cells and the absence
of these receptors in the membranes of tumour cells (Wood
& Gollahon, 1977; Lindsay et al., 1982). This principle was
successfully employed by Olive (1989) to separate tumour
and host cells (derived from murine SCCVII tumour) by
FACS using FITC-conjugated antimouse IgG. Over 95% of
the IgG positive cells in SCCVII tumour were identified as
tumour associated macrophages (TAM) (Olive, 1989). The
IgG negative fraction contains tumour cells contaminated
with 5-10% of diploid cells, presumably host cells devoid of
Fc receptor.
In this work we combined the above method for separa-
tion of host and tumour cells with simultaneous excitation
and fluorescence measurement of photosensitiser Photofrin
using a dual laser FACS apparatus. This enabled determina-
tion of precise distribution of Photofrin between malignant
tumour cells (IgG negative) and host cells (IgG positive)
contained in a murine tumours. The work by Chan et al.
(1988) has shown that host cells other than macrophages
(lymphocytes and polymorphonuclear leukocytes) do not
accumulate photosensitiser A1ClSPC. It seems reasonable to
expect a similar selectivity with Photofrin to be accumulated
in macrophages and not in the other host cells, although this
remains to be experimentally verified. Since, in addition,
most of the host cells are TAM, the IgG positive cells which
in this work were shown to have high levels of Photofrin
could in fact be identified as macrophages.
The experimental data presented in this work demonstrate
that at least up to 4 days after Photofrin administration there
is more drug accumulated in IgG positive than in IgG nega-
tive cells. Taking into account the content of host cells in
SCCVII tumour (-40%), the data indicate that most of the
photosensitiser material is in fact contained in TAM, not in
the tumour cells. This is particularly pronounced between 4
and 24 h postadministration of Photofrin when there is up to
three times more photosensitiser in IgG positive than in IgG
negative cells on per cell basis. Based on per cell protein
calculation, this ratio is greater than nine for IgG + over
IgG - cells.
The measurement of cellular Photofrin content by FACS
was verified by an independent measurement of the drug
content in sorted cells using chemical extraction of porphyrin
followed by a fluorometric assay. This other method, how-
ever, includes hydrolysis and disaggregation of porphyrin
material, which results in conversion of all photosensitiser
components into a more uniform material with optimal
fluorescence yield (Korbelik & Hung, 1991; Brown & Ver-
non, 1990). This is not the case with Photofrin fluorescence
measurement in live cells during the FACS sorting, which
registers the fluorescence intensity strongly dominated by
highly fluorescing monomeric species, and does not reflect the
concentration of highly aggregated and less-fluorescening
species of this drug (Moan & Sommer, 1983; Brown &
Vernon, 1990). The total Photofrin content in the cells not
determined by the FACS measurement has thus been assess-
ed by the extraction method.
The comparison of the results obtained with these two
methods for Photofrin measurement (Figure 4) does not
reveal any major discrepancies, both methods show higher
levels of sensitiser in IgG positive compared to IgG negative
cells. The only possible difference may be in the time when
maximal value for IgG + /IgG - for Photofrin levels is
reached. This peak time is observed earlier with the extrac-
tion method (4 h postadministration), than with FACS
measurement (12 h postadministration); however, this cannot
be fully supported by statistical calculation (see Figure 4).
This possible difference is not unexpected, since at the highest
Photofrin levels, attained 4 h postadministration, much of the
drug in the cells could be in highly aggregated form and thus
underestimated by the FACS measurement. A few hours
later, following intracellular dissociation of its aggregates,
Photofrin can reach its strongest fluorescence.
There seem to exist two potential impediments to the
FACS method used in this work. The procedure for disper-
sion of the tumour into single cell suspension takes time
(more than 1 h) and exposes cells to digestion enzymes; all of
which could result in some loss of photosensitiser from the
cells. The other potential problem is photodestruction
(photobleaching) of Photofrin by exposure to the strong
excitation light (FACS laser). This exposure is, however, very
short. Moreover, there are no indications that the rate of
photodestruction is different in tumour and host cells under
our experimental conditions. In a control experiment, in
which TAM were separated from tumour cells by taking
advantage of their much more rapid attachment to the plastic
substrate, a 4.9 times higher level of Photofrin in TAM
enriched population compared to tumour cell fraction was
detected (Table I). In this case FAGS was not used, and thus
there could be no Photofrin photodestruction.
Compared to the TAM population sorted by FACS, the
population of TAM selected by the differential attachment
procedure may be enriched in activated macrophages. The
most likely reason for this difference is that not all macro-
phages contained in IgG positive tumour fraction would
attach to the substrate. The non-attaching TAM, which are
probably not in an activated state and thus less active in
phagocytising Photofrin than attaching TAM, are lost in the
differential attachment procedure. This factor seems most
likely to be responsible for a difference in Photofrin levels
found in the TAM populations selected by these two tech-
niques.
We have also addressed the concern that the enzymatic
dissociation procedure, used for obtaining single cell suspen-
sion from tumours could induce a different loss of Photofrin
from TAM and tumour cells. The Photofrin loss seen in the
experiment designed to examine this issue (Table II) was
greater in macrophages than in tumour cells. This suggests
that higher Photofrin levels in IgG positive cells compared to
IgG negative cells (Figures 2-4) could not be an artefact
induced by the enzymatic dissociation procedure. It should
be also noted, that the enzymatic treatment (exposure to the
cocktail consisting of trypsin, collagenase and DNAase, for
30 min at 37C) is much harsher to isolated cells attached to
the Petri dish substrate (although no cell lysis was detected)
than to cells contained in pieces of tumour tissue. The loss of
Photofrin from cells during the tumour dissociation is,
therefore, probably considerably lower than under conditions
of the in vitro experiment. In the same experiment, it was
shown that in vitro peritoneal macrophages and TAM exhibit
higher capacity of Photofrin uptake than SCCVII tumour
cells (Table II). More detailed analysis of Photofrin uptake
and clearance from macrophages and SCCVII tumour cells is
reported elsewhere (Korbelik et al., 1991).
The data presented in this study offer clear evidence that in
SCCVII murine tumour much higher levels of Photofrin are
accumulated in TAM than in tumour cells. This result
strongly supports previously published, but less direct evi-
dence and suggestions by a number of investigators (Bugelski
et al., 1981; Chan et al., 1988; Jori, 1989; Henderson &512 M. KORBELIK et al.
Bellnier, 1989). The high content of TAM in the SCCVII
tumour is by no means unusual. There is increasing evidence
that many animal and human tumours are characterised by a
relatively high macrophage content (e.g. Lindsay et al., 1982;
Milas et al., 1987; Eccles & Alexander, 1974; Svennvig &
Svaar, 1979). It remains to be verified that a similar pattern
of distribution of Photofrin and other photosensitisers
between TAM and tumour cells could be found in other
tumours. With Lewis lung carcinoma grown on C57B1 mice
and using the FACS technique described in this work, we
have obtained approximately 3.6 times higher Photofrin
levels in IgG positive than in IgG negative cells at 24 h after
photosensitiser administration (Korbelik, 1991).
In tumours with high macrophage content the preferential
accumulation of Photofrin in TAM could significantly con-
tribute to tumour localisation of Photofrin in tumour tissue.
The fact that most of photosensitiser material could be
accumulated in TAM population has obviously important
implications for PDT. Light energy dependent production of
TNF by murine macrophages has been demonstrated after in
vitro PDT using Photofrin (Evans et al., 1990). Release of
large amounts of prostaglandin E from peritoneal murine
macrophages after Photofrin-based PDT has also been
reported (Henderson & Donovan, 1989). There are strong
indications that PDT-induced immunosuppression (Lynch et
al., 1989) and lethality due to TNF-induced cahexia follow-
ing PDT are mediated by macrophages (Ferrario & Gomer,
1990; Darling et al., 1990).
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